Showing results (101-110 of 154) with videos related to

Sort By:
Pageof 16
Multiple Sclerosis and Related Disorders|June 1, 2020
The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosisCharmaine Yam, Daniel Merlo, Jim Stankovich, et al.
Plos One|November 8, 2024
Reef visitors' observation of assisted coral recovery devices in situ reduces concern about their useMatthew I Curnock, Rhea Arya, Emilee Chamberland, et al.
Neurology|September 24, 2021
Association Between Cognitive Trajectories and Disability Progression in Patients With Relapsing-Remitting Multiple SclerosisDaniel Merlo, Jim Stankovich, Claire Bai, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 27, 2025
Toward a global research agenda for preventing multiple sclerosisRuth Ann Marrie, Ruth Dobson, Sergio E Baranzini, et al.
Multiple Sclerosis and Related Disorders|January 25, 2026
The association between flavonoid intake and first clinical diagnosis of central nervous system demyelination: a case-control studyWolfgang Marx, Mojtaba Lotfaliany, Lucinda J Black, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|August 27, 2020
Effects of Dating Matters® on Sexual Violence and Sexual Harassment Outcomes among Middle School Youth: a Cluster-Randomized Controlled TrialSarah DeGue, Phyllis Holditch Niolon, Lianne Fuino Estefan, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|March 8, 2024
High School Follow-Up of the Dating Matters® RCT: Effects on Teen Dating Violence and Relationship BehaviorsPhyllis Holditch Niolon, Lianne F Estefan, Sarah DeGue, et al.
JMIR Research Protocols|October 19, 2021
Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)Vicki E Maltby, Rodney A Lea, Mastura Monif, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 1, 2025
Long-term acceptability of MSReactor digital cognitive monitoring among people living with multiple sclerosisDaniel Merlo, Johnson Ja, Yi Chao Foong, et al.
Genome Medicine|May 2, 2019
Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibilityAli Afrasiabi, Grant P Parnell, Nicole Fewings, et al.
Pageof 16